|
|
311 Bonnie Circle
Corona, CA 92880 USA
phone:(909) 493-5300
fax:(973) 355-8301
|
|
| Symbol |
WPI |
| Exchange |
NYSE |
| Founded |
0 |
| Employees |
3983 |
|
|
| www.watsonpharm.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Makes branded and generic pharmaceutical products. |
|
| Management |
| Paul M. Bisaro, President and Chief Executive Officer; David A. Buchen, Senior Vice President, General Counsel and Secretary; Clare Carmichael, Senior Vice President, Human Resources; Mark W. Durand, Senior Vice President and Chief Financial Officer; Charles D. Ebert, Ph.D., Senior Vice President, Research and Development; Thomas R. Giordano, Senior Vice President, Chief Information Officer; Edward F. Heimers, Jr., Executive Vice President, President Brand Division; Gordon Munro, Ph.D., Senior Vice President, Quality Assurance; Albert Paonessa III, Executive Vice President and Chief Operating Officer, Anda, Inc., Watson's distribution subsidiary; Thomas R. Russillo Executive Vice President, President U.S. Generics Division |
| |
|
|
|
|
|
|
|
| Keywords |
| pharmaceutical, drug delivery, depression,lupus, female sexual dysfunction, DrugDelivery |
|
|
|
| Description |
|
Watson Pharmaceuticals Inc. is engaged in the development, manufacture, marketing, sale and distribution of branded and off-patent (generic) pharmaceutical products. |
|
| Technology / Differentiation |
| Watson Pharmaceuticals makes brand and generic pharmaceutical products utilizing various drug delivery technologies, including solid dosage form, oral controlled release, transdermal, and oral transmucosal delivery systems. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
